DRUG

NASDAQStock

Bright Minds Biosciences Inc.

$73.50+1.48 (+2.05%)

52-Week Range

$23.27

$95.98

Key Stats

Market Cap

570.5M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-0.75

Volume

72.6K

Avg Volume

107.8K

Performance

-7.28%

-15.66%

+48.48%

YTD

-13.43%

+100.36%

+2733.33%

+74.94%

Price Chart

ETF Exposure

DRUG is held by 21 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	4.92%	11,813	$1.0M	$20.4M	1.84%
VFMO	Vanguard U.S. Momentum Factor ETF	0.07%	11,455	$894K	$1.30B	0.13%
GWX	State Street SPDR S&P International Small Cap ETF	0.07%	7,452	$578K	$865.1M	0.40%
VTWG	Vanguard Russell 2000 Growth ETF	0.03%	4,667	$363K	$1.50B	0.06%
RSSL	Global X - Russell 2000 ETF	0.01%	2,326	$201K	$1.38B	0.08%
RESM	Columbia Research Enhanced Small Cap ETF	0.01%	5	$398	$3.1M	0.32%
VTWO	Vanguard Russell 2000 ETF	0.01%	24,048	$1.9M	$14.50B	0.06%
UWM	ProShares - Ultra Russell2000	0.01%	305	$24K	$264.2M	1.07%
URTY	ProShares - UltraPro Russell2000	0.01%	302	$24K	$309.0M	1.08%
SMMD	iShares Russell 2500 ETF	0.00%	1,798	$143K	$2.33B	0.23%
HDG	ProShares - Hedge Replication ETF	0.00%	6	$477	$23.2M	0.95%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	0	$33	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	1	$111	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	2	$189	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	3	$217	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	3	$257	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	3	$214	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	2	$141	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	1	$107	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	1	$47	$9.5M	0.12%
VTHR	Vanguard Russell 3000 ETF	0.00%	352	$27K	$5.50B	0.06%

About DRUG ETF Exposure

Bright Minds Biosciences Inc. (DRUG) is held by 21 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 570.5M, DRUG is a widely held institutional stock. The stock currently trades at $73.50. Investors can gain exposure to DRUG through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DRUG, sorted by portfolio weight.